Literature DB >> 22972052

Topical treatments for cutaneous warts.

Chun Shing Kwok1, Sam Gibbs, Cathy Bennett, Richard Holland, Rachel Abbott.   

Abstract

BACKGROUND: Viral warts are a common skin condition, which can range in severity from a minor nuisance that resolve spontaneously to a troublesome, chronic condition. Many different topical treatments are available.
OBJECTIVES: To evaluate the efficacy of local treatments for cutaneous non-genital warts in healthy, immunocompetent adults and children. SEARCH
METHODS: We updated our searches of the following databases to May 2011: the Cochrane Skin Group Specialised Register, CENTRAL in The Cochrane Library, MEDLINE (from 2005), EMBASE (from 2010), AMED (from 1985), LILACS (from 1982), and CINAHL (from 1981). We searched reference lists of articles and online trials registries for ongoing trials. SELECTION CRITERIA: Randomised controlled trials (RCTs) of topical treatments for cutaneous non-genital warts. DATA COLLECTION AND ANALYSIS: Two authors independently selected trials and extracted data; a third author resolved any disagreements. MAIN
RESULTS: We included 85 trials involving a total of 8815 randomised participants (26 new studies were included in this update). There was a wide range of different treatments and a variety of trial designs. Many of the studies were judged to be at high risk of bias in one or more areas of trial design.Trials of salicylic acid (SA) versus placebo showed that the former significantly increased the chance of clearance of warts at all sites (RR (risk ratio) 1.56, 95% CI (confidence interval) 1.20 to 2.03). Subgroup analysis for different sites, hands (RR 2.67, 95% CI 1.43 to 5.01) and feet (RR 1.29, 95% CI 1.07 to 1.55), suggested it might be more effective for hands than feet.A meta-analysis of cryotherapy versus placebo for warts at all sites favoured neither intervention nor control (RR 1.45, 95% CI 0.65 to 3.23). Subgroup analysis for different sites, hands (RR 2.63, 95% CI 0.43 to 15.94) and feet (RR 0.90, 95% CI 0.26 to 3.07), again suggested better outcomes for hands than feet. One trial showed cryotherapy to be better than both placebo and SA, but only for hand warts.There was no significant difference in cure rates between cryotherapy at 2-, 3-, and 4-weekly intervals.Aggressive cryotherapy appeared more effective than gentle cryotherapy (RR 1.90, 95% CI 1.15 to 3.15), but with increased adverse effects.Meta-analysis did not demonstrate a significant difference in effectiveness between cryotherapy and SA at all sites (RR 1.23, 95% CI 0.88 to 1.71) or in subgroup analyses for hands and feet.Two trials with 328 participants showed that SA and cryotherapy combined appeared more effective than SA alone (RR 1.24, 95% CI 1.07 to 1.43).The benefit of intralesional bleomycin remains uncertain as the evidence was inconsistent. The most informative trial with 31 participants showed no significant difference in cure rate between bleomycin and saline injections (RR 1.28, 95% CI 0.92 to 1.78).Dinitrochlorobenzene was more than twice as effective as placebo in 2 trials with 80 participants (RR 2.12, 95% CI 1.38 to 3.26).Two trials of clear duct tape with 193 participants demonstrated no advantage over placebo (RR 1.43, 95% CI 0.51 to 4.05).We could not combine data from trials of the following treatments: intralesional 5-fluorouracil, topical zinc, silver nitrate (which demonstrated possible beneficial effects), topical 5-fluorouracil, pulsed dye laser, photodynamic therapy, 80% phenol, 5% imiquimod cream, intralesional antigen, and topical alpha-lactalbumin-oleic acid (which showed no advantage over placebo).We did not identify any RCTs that evaluated surgery (curettage, excision), formaldehyde, podophyllotoxin, cantharidin, diphencyprone, or squaric acid dibutylester. AUTHORS'
CONCLUSIONS: Data from two new trials comparing SA and cryotherapy have allowed a better appraisal of their effectiveness. The evidence remains more consistent for SA, but only shows a modest therapeutic effect. Overall, trials comparing cryotherapy with placebo showed no significant difference in effectiveness, but the same was also true for trials comparing cryotherapy with SA. Only one trial showed cryotherapy to be better than both SA and placebo, and this was only for hand warts. Adverse effects, such as pain, blistering, and scarring, were not consistently reported but are probably more common with cryotherapy.None of the other reviewed treatments appeared safer or more effective than SA and cryotherapy. Two trials of clear duct tape demonstrated no advantage over placebo. Dinitrochlorobenzene (and possibly other similar contact sensitisers) may be useful for the treatment of refractory warts.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22972052      PMCID: PMC8101088          DOI: 10.1002/14651858.CD001781.pub3

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  113 in total

1.  Randomized, double-blind, placebo-controlled pilot study to assess the value of free radical scavengers in reducing inflammation induced by cryotherapy.

Authors:  J E Gach; F Humphreys; J Berth-Jones
Journal:  Clin Exp Dermatol       Date:  2005-01       Impact factor: 3.470

Review 2.  Warts and molluscum contagiosum: beware of treatments worse than the disease.

Authors:  E Ordoukhanian; A T Lane
Journal:  Postgrad Med       Date:  1997-02       Impact factor: 3.840

3.  A double-blind, randomized trial of local formic acid puncture technique in the treatment of common warts.

Authors:  Gita Faghihi; Anahita Vali; Mohammadreza Radan; Golamreza Eslamieh; Shadi Tajammoli
Journal:  Skinmed       Date:  2010 Mar-Apr

4.  [Virostatic treatment of eruptive warts. Preliminary report].

Authors:  E G Jung; A Grafe
Journal:  Dtsch Med Wochenschr       Date:  1971-11-26       Impact factor: 0.628

5.  Controlled intralesional deposition of a sclerotic agent in verruca therapy.

Authors:  R K Locke; K Zang
Journal:  Int J Dermatol       Date:  1970 Oct-Dec       Impact factor: 2.736

6.  Value of a second freeze-thaw cycle in cryotherapy of common warts.

Authors:  J Berth-Jones; J Bourke; H Eglitis; C Harper; P Kirk; S Pavord; R Rajapakse; P Weston; T Wiggins; P E Hutchinson
Journal:  Br J Dermatol       Date:  1994-12       Impact factor: 9.302

7.  Application of beta-interferon in virus-induced papillomas.

Authors:  M Niimura
Journal:  J Invest Dermatol       Date:  1990-12       Impact factor: 8.551

Review 8.  Efficacy of topical treatments for cutaneous warts: a meta-analysis and pooled analysis of randomized controlled trials.

Authors:  C S Kwok; R Holland; S Gibbs
Journal:  Br J Dermatol       Date:  2011-05-26       Impact factor: 9.302

9.  The efficacy of duct tape vs cryotherapy in the treatment of verruca vulgaris (the common wart).

Authors:  Dean R Focht; Carole Spicer; Mary P Fairchok
Journal:  Arch Pediatr Adolesc Med       Date:  2002-10

10.  The descriptive epidemiology of warts in British schoolchildren.

Authors:  H C Williams; A Pottier; D Strachan
Journal:  Br J Dermatol       Date:  1993-05       Impact factor: 9.302

View more
  42 in total

1.  Various tumors in the nasal vestibule.

Authors:  So Jeong Kim; Sung Wan Byun; Seung-Sin Lee
Journal:  Int J Clin Exp Pathol       Date:  2013-11-15

2.  Duct tape for warts in children: Should nature take its course?

Authors:  Ran D Goldman
Journal:  Can Fam Physician       Date:  2019-05       Impact factor: 3.275

3.  Management of Difficult-to-Treat Warts: Traditional and New Approaches.

Authors:  Peter C Friedman
Journal:  Am J Clin Dermatol       Date:  2021-01-11       Impact factor: 7.403

4.  Are salicylic formulations, liquid nitrogen or duct tape more effective than placebo for the treatment of warts in paediatric patients who present to ambulatory clinics?

Authors:  Lindsey Craw; Aireen Wingert; Irene Lara-Corrales
Journal:  Paediatr Child Health       Date:  2014-03       Impact factor: 2.253

5.  Monochloroacetic acid application is an effective alternative to cryotherapy for common and plantar warts in primary care: a randomized controlled trial.

Authors:  Sjoerd C Bruggink; Jacobijn Gussekloo; Paulette F Egberts; Jan Nico Bouwes Bavinck; Margot W M de Waal; Willem J J Assendelft; Just A H Eekhof
Journal:  J Invest Dermatol       Date:  2015-02-05       Impact factor: 8.551

6.  What works best for nongenital warts?

Authors:  Caitlin Finley; Christina Korownyk; Michael R Kolber
Journal:  Can Fam Physician       Date:  2016-12       Impact factor: 3.275

7.  Bleomycin-Coated Microneedles for Treatment of Warts.

Authors:  Han Sol Lee; Ha Ryeong Ryu; Joo Young Roh; Jung-Hwan Park
Journal:  Pharm Res       Date:  2016-11-17       Impact factor: 4.200

8.  Topical 15% Zinc Oxide Ointment Significantly Reduces the Size of Common Warts After Four Weeks: A Randomized, Triple-blinded, Placebo-controlled Trial.

Authors:  Chankiat Songsantiphap; Pravit Asawanonda
Journal:  J Clin Aesthet Dermatol       Date:  2019-09-01

Review 9.  Opportunities and challenges for human papillomavirus vaccination in cancer.

Authors:  Richard B S Roden; Peter L Stern
Journal:  Nat Rev Cancer       Date:  2018-03-02       Impact factor: 60.716

10.  Efficacy of pulsed dye laser treatment for common warts is not influenced by the causative HPV type: a prospective study.

Authors:  Yoseph Fichman; Assi Levi; Emmilia Hodak; Shlomit Halachmi; Sigal Mazor; Dana Wolf; Orit Caplan; Moshe Lapidoth
Journal:  Lasers Med Sci       Date:  2017-12-07       Impact factor: 3.161

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.